Wang Wei, Nacusi Lucas, Sheaff Robert J, Liu Xuedong
Department of Chemistry and Biochemistry, University of Colorado-Boulder, Boulder, Colorado 80309, USA.
Biochemistry. 2005 Nov 8;44(44):14553-64. doi: 10.1021/bi051071j.
Multiple proteolytic pathways are involved in the degradation of the cyclin-dependent kinase inhibitor p21(Cip1/WAF1). Timed destruction of p21(Cip1/WAF1) plays a critical role in cell-cycle progression and cellular response to DNA damage. The SCF(Skp2) complex (consisting of Rbx1, Cul1, Skp1, and Skp2) is one of the E3 ubiquitin ligases involved in ubiquitination of p21(Cip1/WAF1). Little is known about how SCF(Skp2) recruits its substrates and selects particular acceptor lysine residues for ubiquitination. In this study, we investigated the requirements for SCF(Skp2) recognition of p21(Cip1/WAF1) and lysine residues that are ubiquitinated in vitro and inside cells. We demonstrate that ubiquitination of p21(Cip1/WAF1) requires a functional interaction between p21(Cip1/WAF1) and the cyclin E-Cdk2 complex. Mutation of both the cyclin E recruitment motif (RXL) and the Cdk2-binding motif (FNF) at the N terminus of p21(Cip1/WAF1) abolishes its ubiquitination by SCF(Skp2), while mutation of either motif alone has minimal effects, suggesting either contact is sufficient for substrate recruitment. Thus, SCF(Skp2) appears to recognize a trimeric complex consisting of cyclin E-Cdk2-p21(Cip1/WAF1). Furthermore, we show that p21(Cip1/WAF1) can be ubiquitinated at four distinct lysine residues located in the carboxyl-terminal region but not two other lysine residues in the N-terminal region. Any one of these four lysine residues can be targeted for ubiquitination in the absence of the others in vitro, and three of these four lysine residues are also ubiquitinated in vivo, suggesting that there is limited specificity in the selection of ubiquitination sites. Interestingly, mutation of the carboxyl-terminal proline to lysine enables ubiquitin conjugation at the carboxyl terminus of the substrate both in vitro and in vivo. Thus, our results highlight a unique property of the ubiquitination enzymatic reaction in that substrate ubiquitination site selection can be remarkably diverse and occur in distinct spatial areas.
多种蛋白水解途径参与细胞周期蛋白依赖性激酶抑制剂p21(Cip1/WAF1)的降解。p21(Cip1/WAF1)的定时破坏在细胞周期进程和细胞对DNA损伤的反应中起关键作用。SCF(Skp2)复合物(由Rbx1、Cul1、Skp1和Skp2组成)是参与p21(Cip1/WAF1)泛素化的E3泛素连接酶之一。关于SCF(Skp2)如何招募其底物并选择特定的接受赖氨酸残基进行泛素化,人们知之甚少。在本研究中,我们研究了SCF(Skp2)识别p21(Cip1/WAF1)以及在体外和细胞内被泛素化的赖氨酸残基的要求。我们证明p21(Cip1/WAF1)的泛素化需要p21(Cip1/WAF1)与细胞周期蛋白E-Cdk2复合物之间的功能性相互作用。p21(Cip1/WAF1)N末端的细胞周期蛋白E招募基序(RXL)和Cdk2结合基序(FNF)的突变均消除了其被SCF(Skp2)泛素化的能力,而单独突变任一基序的影响最小,这表明任何一种接触都足以招募底物。因此,SCF(Skp2)似乎识别由细胞周期蛋白E-Cdk2-p21(Cip1/WAF1)组成的三聚体复合物。此外,我们表明p21(Cip1/WAF1)可在位于羧基末端区域的四个不同赖氨酸残基处被泛素化,但在N末端区域的另外两个赖氨酸残基处则不会。在体外,这四个赖氨酸残基中的任何一个在没有其他残基的情况下都可成为泛素化的靶点,并且这四个赖氨酸残基中的三个在体内也会被泛素化,这表明在泛素化位点的选择上特异性有限。有趣的是,将羧基末端的脯氨酸突变为赖氨酸可使底物在体外和体内的羧基末端进行泛素结合。因此,我们的结果突出了泛素化酶促反应的一个独特特性,即底物泛素化位点的选择可以非常多样,并且发生在不同空间区域。